Abstract
Enhancing the aqueous solubility via amorphization of crystalline poor glass-forming drugs represents a challenge, particularly when drug dosing is high. In such scenarios, there is often a need for high polymer loadings leading to an increase in the dosage form mass and less patient acceptability. This work investigated the role that polymer type and after-melt cooling rate had upon the amorphicity of solid dispersions (SDs) containing high levels of naproxen and three commonly used polymeric excipients: Eudragit® EPO, Kollidon® VA64, and Soluplus®. Using a combination of thermogravimetry, conventional and fast-scan DSC, oscillatory rheology, in silico Hansen solubility parameter computation, FTIR, and PXRD, we have shown that amorphicity could be affected by the cooling rate with the specific polymer type and amount playing a significant role in the degree of this impact. The amorphous drug content, evident at higher cooling rates, was found to be dependent on drug-polymer interaction and polymer melt viscosity. Higher polymer concentration and faster cooling produced less melt crystallization upon cooling, which was attributed to a shift in nucleation to lower temperatures where it could be inhibited by polymer matrix viscosity. Amorphous drug content, which contained drug nuclei, was evidenced by cold crystallization upon reheating. After 4 weeks of 'gentle' storage, cold crystallization increased if nucleation was the dominant process, whereas cold crystallization decreased if crystal growth prevailed. Storage at elevated temperature and humidity resulted in the absence of cold crystallization, and increased melt crystallisation. Thus, faster cooling could serve as an additional tool to improve amorphous yield and stability of high drug-loaded SDs, however, intermolecular polymer-drug interaction, melt viscosity of the drug-polymer matrix, and storage conditions are of critical importance to achieve this goal.
| Original language | English |
|---|---|
| Article number | 125095 |
| Journal | International Journal of Pharmaceutics |
| Volume | 670 |
| DOIs | |
| Publication status | Published - 10 Feb 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Keywords*
- Amorphous stability
- Naproxen
- Solid dispersion
- Cooling rate
- Nucleation crystallization
Field of Science*
- 3.1 Basic medicine
- 1.4 Chemical sciences
- 2.4 Chemical engineering
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
Fingerprint
Dive into the research topics of 'High drug-loaded amorphous solid dispersions of a poor glass forming drug: The impact of polymer type and cooling rate on amorphous drug behaviour'. Together they form a unique fingerprint.-
Combined pre-formulation approach for the selection of naproxen-polymer-solvent candidates for the preparation of amorphous solid dispersion
Gurkina, K., Horvath, Z. M., Kačanovs, R. & Mohylyuk, V. (Corresponding Author), 24 Mar 2026. 1 p.Research output: Contribution to conference › Poster › peer-review
Open Access -
Amorphous solid dispersion tablet active coating in a perforated pan coater: proof of concept
Raciborska, L., Buczkowska, E. M., Kukuls, K. & Mohylyuk, V. (Corresponding Author), 1 Oct 2025. 1 p.Research output: Contribution to conference › Poster
-
Kinetic stabilization of amorphous naproxen in its high-drug loaded solid dispersions: impact of the polymer type and after-melt cooling rate
Kolisnyk, T., Mohylyuk, V. & Andrews, G. P., 21 Mar 2024. 1 p.Research output: Contribution to conference › Poster › peer-review
Open AccessFile
Projects
- 1 Finished
-
Preparation of Polymer-Based Amorphous Solid Dispersions of Poorly Soluble Drugs With a Bad Glass-Forming Ability
Mohylyuk, V. (Participant) & Kolisnyk, T. (Participant)
13/03/23 → 30/09/24
Project: Projects outside RSU
-
Formulation Approaches to Improve Physico-Chemical Properties of Furosemide Amorphous Solid Dispersions
Saršūns, K. (Speaker), Anspoka, N. (Co-author), Meija, R. (Co-author), Viter, R. (Co-author), Mohylyuk, V. (Co-author) & Bērziņš, A. (Co-author)
11 Aug 2026 → 18 Aug 2026Activity: Talk or presentation types › Poster presentation
-
Combined pre-formulation approach for the selection of naproxen-polymer-solvent candidates for the preparation of amorphous solid dispersion
Gurkina, K. (Speaker), Kačanovs, R. (Co-author), Horvath, Z. M. (Co-author) & Mohylyuk, V. (Co-author)
23 Mar 2026 → 26 Mar 2026Activity: Talk or presentation types › Poster presentation
-
Marcin Skotinicki
Mohylyuk, V. (Host)
7 Apr 2025 → 11 Apr 2025Activity: Hosting a visitor types › Hosting an academic visitor
Press/Media
-
NEWS> High drug-loaded amorphous solid dispersions of a poor glass forming drug: The impact of polymer type and cooling rate on amorphous drug behaviour
Kolisnyk, T., Mohylyuk, V. & Andrews, G. P.
23/12/24
1 item of Media coverage
Press/Media
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver